Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BTIG analyst Jeet Mukherjee downgraded Foghorn Therapeutics Inc (NASDAQ:FHTX) from Buy to Neutral. Foghorn Therapeutics closed at $2.92 on Thursday. See how other analysts view this stock.
- Piper Sandler analyst Nathan Race downgraded First Busey Corp (NASDAQ:BUSE) from Overweight to Neutral and cut the price target from $35 to $30. First Busey shares closed at $29.46 on Thursday. See how other analysts view this stock.
- B. Riley Securities analyst Mike Crawford downgraded AST SpaceMobile Inc (NASDAQ:ASTS) from Buy to Neutral and cut the price target from $85 to $65. AST SpaceMobile closed at $57.04 on Thursday. See how other analysts view this stock.
- Freedom Capital Markets analyst Keith Hinton downgraded AtriCure Inc (NASDAQ:ATRC) from Buy to Hold and raised the price target from $43 to $57. AtriCure shares closed at $53.59 on Thursday. See how other analysts view this stock.
- Piper Sandler analyst Nathan Race downgraded Equity BancShares Inc (NYSE:EQBK) from Overweight to Neutral and cut the price target from $60 to $52. Equity Bancshares closed at $47.48 on Thursday. See how other analysts view this stock.
Considering buying ASTS stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment